Related Experiment Video
Updated: Aug 14, 2026

Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults
Published on: July 16, 2016
Sweet syndrome in two children
Mark D Herron1, Cheryl M Coffin, Sheryll L Vanderhooft
1Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
Insights
Acute febrile neutrophilic dermatosis (Sweet syndrome) in children can present differently. Corticosteroid treatment showed varied responses and side effects in two pediatric cases.
Area of Science:
- Pediatric Dermatology
- Rheumatology
Background:
- Acute febrile neutrophilic dermatosis, or Sweet syndrome, is a rare inflammatory condition.
- While typically associated with underlying conditions in adults, pediatric cases are less understood.
Observation:
- Two pediatric patients, a 9-month-old girl and a 4-year-old boy, presented with Sweet syndrome.
- Both exhibited characteristic symptoms including fever, leukocytosis, and skin lesions following an infection.
Findings:
- Neither child showed signs of malignancy or chronic systemic illness.
- The 4-year-old boy responded well to systemic corticosteroids, while the infant experienced disease flares during tapering.
- Corticosteroid use led to behavioral changes in the boy and growth retardation in the infant, both resolving upon cessation.
Implications:
- This case series highlights the variable presentation and treatment response of Sweet syndrome in pediatric patients.
- It underscores the need for careful monitoring of side effects, such as behavioral changes and growth issues, during corticosteroid therapy in children.
- Further research is needed to elucidate optimal management strategies for pediatric Sweet syndrome.
Abstract:
We report a 9-month-old girl and a 4-year-old boy with acute febrile neutrophilic dermatosis (Sweet syndrome). Both children were febrile, had leukocytosis, and exhibited lesions characteristic of Sweet syndrome. Both had an antecedent infection. Our evaluation and long-term follow-up of these children failed to reveal evidence of underlying malignancy or a chronic systemic illness typically encountered in Sweet syndrome. Of interest, the 4-year-old boy responded to systemic corticosteroids with remission, whereas the 9-month-old infant experienced flaring of the disease on successive attempts to taper the systemic corticosteroids. Systemic corticosteroid usage was associated with alteration in behavior in the 4-year-old and transient growth retardation in the 9-month-old. In both patients, the adverse effects resolved after discontinuation of the corticosteroids.
Related Concept Videos
Synesthesia
Sex-linked Disorders
Hyperosmolar Hyperglycemic State
Nondisjunction
Pyloric Obstruction
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
